In accord with these findings in ovarian carcinoma, Cldn4 expression has been reported to be reduced in the majority of gastric cancers and lower expression levels correlate with poorly-differentiated gastric adenocarcinomas [28]. This evidence concerns the gene CLDN4 and gastric adenocarcinoma.